帕博西尼诱发的中毒性表皮坏死松解症：1例病例报告及对细胞周期蛋白依赖性激酶4/6抑制剂所致所有病例的综述 - Suppr

Suppr

超能文献

Palbociclib-induced Toxic Epidermal Necrolysis: A Case Report with Review of All Cases Secondary to Cyclin-dependent Kinase 4/6 Inhibitors.

作者信息

Devoldere Aurore, Vanhaecke Clélia, Soibinet Pauline, Azzouz Brahim, Viguier Manuelle

机构信息

Dermatology department, Reims University Hospital, Reims, France.

Medical Oncology Department, Godinot Institute, Reims, France.

出版信息

Acta Derm Venereol. 2025 Jan 14;105:adv42291. doi: 10.2340/actadv.v105.42291.

DOI:10.2340/actadv.v105.42291

PMID:39810428

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11748170/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab1c/11748170/32d31dff626d/ActaDV-105-42291-g001.jpg

相似文献

Palbociclib-induced Toxic Epidermal Necrolysis: A Case Report with Review of All Cases Secondary to Cyclin-dependent Kinase 4/6 Inhibitors.帕博西尼诱发的中毒性表皮坏死松解症：1例病例报告及对细胞周期蛋白依赖性激酶4/6抑制剂所致所有病例的综述

Acta Derm Venereol. 2025 Jan 14;105:adv42291. doi: 10.2340/actadv.v105.42291.

Stevens-Johnson syndrome-like eruption from palbociclib in a patient with metastatic breast cancer.一名转移性乳腺癌患者使用哌柏西利后出现类史蒂文斯-约翰逊综合征皮疹。

JAAD Case Rep. 2018 Apr 30;4(5):452-454. doi: 10.1016/j.jdcr.2017.12.015. eCollection 2018 Jun.

Role of cyclin-dependent kinase 4/6 inhibitors in the current and future eras of cancer treatment.细胞周期蛋白依赖性激酶4/6抑制剂在当前及未来癌症治疗时代的作用

J Oncol Pharm Pract. 2019 Jan;25(1):110-129. doi: 10.1177/1078155218770904. Epub 2018 May 4.

Elevated transaminases and development of cardiomyopathy in a 32-year-old woman with metastatic breast cancer after treatment with ribociclib followed by palbociclib.一名 32 岁转移性乳腺癌女性患者在接受了瑞博西利（ribociclib）治疗后又接受了帕博西利（palbociclib）治疗，出现了转氨基酶升高和心肌病。

J Oncol Pharm Pract. 2023 Jun;29(4):962-966. doi: 10.1177/10781552221122057. Epub 2022 Aug 24.

Cyclin-dependent protein kinase inhibitors including palbociclib as anticancer drugs.细胞周期蛋白依赖性蛋白激酶抑制剂包括帕博西尼作为抗癌药物。

Pharmacol Res. 2016 May;107:249-275. doi: 10.1016/j.phrs.2016.03.012. Epub 2016 Mar 16.

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Association with Commonly Prescribed Drugs in Outpatient Care Other than Anti-Epileptic Drugs and Antibiotics: A Population-Based Case-Control Study.史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症与门诊护理中除抗癫痫药和抗生素以外的常用药物有关：一项基于人群的病例对照研究。

Drug Saf. 2019 Jan;42(1):55-66. doi: 10.1007/s40264-018-0711-x.

Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.与选择性环氧化酶-2抑制剂相关的史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症报告情况的比较。

Drug Saf. 2005;28(10):917-24. doi: 10.2165/00002018-200528100-00008.

Bronchiolitis obliterans associated with toxic epidermal necrolysis induced by infection: A case report and literature review.感染诱发中毒性表皮坏死松解症相关的闭塞性细支气管炎：一例报告及文献复习

Front Pediatr. 2023 Mar 2;11:1116166. doi: 10.3389/fped.2023.1116166. eCollection 2023.

Ofloxacin: a probable cause of toxic epidermal necrolysis.氧氟沙星：中毒性表皮坏死松解症的一个可能病因。

Ann Pharmacother. 2001 Nov;35(11):1388-90. doi: 10.1345/aph.1Z433.

A current and comprehensive review of cyclin-dependent kinase inhibitors for the treatment of metastatic breast cancer.用于治疗转移性乳腺癌的细胞周期蛋白依赖性激酶抑制剂的最新全面综述。

Curr Med Res Opin. 2017 Sep;33(9):1559-1569. doi: 10.1080/03007995.2017.1348344. Epub 2017 Jul 25.

本文引用的文献

CDK4/6 inhibitors in the treatment of metastatic breast cancer: Focus on toxicity and safety.CDK4/6 抑制剂在转移性乳腺癌治疗中的应用：关注毒性和安全性。

Semin Oncol. 2023 Dec;50(6):131-139. doi: 10.1053/j.seminoncol.2024.01.002. Epub 2024 Jan 13.

Dermatologic toxicities to inhibitors of cyclin-dependent kinases CDK 4 and 6: An updated review for clinical practice.细胞周期蛋白依赖性激酶 CDK 4 和 6 抑制剂的皮肤毒性：临床实践的最新综述。

Ann Dermatol Venereol. 2023 Sep;150(3):208-212. doi: 10.1016/j.annder.2022.11.013. Epub 2023 Aug 14.

Ribociclib and palbociclib-induced erythema multiforme: a case report.瑞博西尼和哌柏西利诱发的多形红斑：一例报告

Oxf Med Case Reports. 2022 Nov 24;2022(11):omac116. doi: 10.1093/omcr/omac116. eCollection 2022 Nov.

Skin Toxicities with Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Signals from Disproportionality Analysis of the FDA Adverse Event Reporting System.乳腺癌中细胞周期蛋白依赖性激酶 4/6 抑制剂的皮肤毒性：来自 FDA 不良事件报告系统的不适当性分析信号。

Am J Clin Dermatol. 2022 Mar;23(2):247-255. doi: 10.1007/s40257-021-00645-0. Epub 2021 Oct 26.

Assessment of Treatment Approaches and Outcomes in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Insights From a Pan-European Multicenter Study.评估 Stevens-Johnson 综合征和中毒性表皮坏死松解症的治疗方法和结局：来自泛欧多中心研究的见解。

JAMA Dermatol. 2021 Oct 1;157(10):1182-1190. doi: 10.1001/jamadermatol.2021.3154.

Cyclin-dependent kinase 4 and 6 inhibitors for hormone receptor-positive breast cancer: past, present, and future.细胞周期蛋白依赖性激酶 4 和 6 抑制剂治疗激素受体阳性乳腺癌：过去、现在和未来。

Lancet. 2020 Mar 7;395(10226):817-827. doi: 10.1016/S0140-6736(20)30165-3.

Anastrozole-Induced Dermatitis: Report of a Woman with an Anastrozole-Associated Dermatosis and a Review of Aromatase Inhibitor-Related Cutaneous Adverse Events.阿那曲唑诱发的皮炎：一例患有阿那曲唑相关性皮肤病的女性病例报告及芳香化酶抑制剂相关皮肤不良事件综述

Dermatol Ther (Heidelb). 2020 Feb;10(1):221-229. doi: 10.1007/s13555-020-00353-3. Epub 2020 Jan 21.

J Breast Cancer. 2019 Dec;22(4):661-666. doi: 10.4048/jbc.2019.22.e44.

Toxic epidermal necrolysis associated with ribociclib in a patient with metastatic breast cancer.一名转移性乳腺癌患者中与瑞博西尼相关的中毒性表皮坏死松解症。

Breast J. 2020 Apr;26(4):773-774. doi: 10.1111/tbj.13570. Epub 2019 Sep 4.

Stevens-Johnson syndrome-like eruption from palbociclib in a patient with metastatic breast cancer.一名转移性乳腺癌患者使用哌柏西利后出现类史蒂文斯-约翰逊综合征皮疹。

JAAD Case Rep. 2018 Apr 30;4(5):452-454. doi: 10.1016/j.jdcr.2017.12.015. eCollection 2018 Jun.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验